|
End-of-day quote
Shanghai S.E.
2026-08-25
|
5-day change | 1st Jan Change | ||
| 9.920 CNY | +5.08% |
|
-1.39% | +2.27% |
| Market Cap | 4.39B 653M 561M 525M 481M 906M 62.4B 908M 6.22B 2.43B 31.45B 2.45B 2.4B 104B | P/E 2024 |
35.9x | P/E 2025 | 88.2x |
|---|---|---|---|---|---|
| Enterprise Value | 3.64B 542M 466M 436M 399M 752M 51.79B 754M 5.16B 2.02B 26.1B 2.04B 1.99B 86.39B | EV / Sales 2024 |
7.4x | EV / Sales 2025 | 8.08x |
| Free-Float |
24.34% | Yield 2024 |
0.62% | Yield 2025 | 0.36% |
| 1 day | +5.08% | ||
| 1 week | -1.39% | ||
| Current month | +20.10% | ||
| 1 month | +21.42% | ||
| 3 months | +12.86% | ||
| 6 months | -4.89% | ||
| Current year | +2.27% |
| 1 week | 9.26 |  | 10.6 |
| 1 month | 7.7 | | 11.33 |
| Current year | 7.02 | | 11.33 |
| 1 year | 7.02 | | 11.96 |
| 3 years | 6.3 | | 14 |
| 5 years | 6.3 | | 28 |
| 10 years | 6.3 | | 28 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ming Jie Guo
CEO | Chief Executive Officer | 53 | 2023-04-05 |
Yi Ming Wu
DFI | Director of Finance/CFO | 57 | 2025-04-29 |
Hui Zhang
IRC | Investor Relations Contact | 44 | 2023-05-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Jun Ye
CHM | Chairman | 53 | 2020-08-17 |
Xiao Ming Ying
BRD | Director/Board Member | 58 | 2012-07-31 |
Si Yu Shen
BRD | Director/Board Member | 44 | 2018-08-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.08% | -1.39% | -18.42% | -9.24% | 649M | |
| +0.73% | +0.70% | +19.56% | +71.29% | 47.78B | |
| -0.37% | +1.04% | +54.31% | +121.86% | 40.3B | |
| +1.23% | -0.14% | -10.12% | +15.55% | 11.88B | |
| +3.41% | +7.67% | +20.38% | +87.48% | 12.03B | |
| +0.19% | 0.00% | +30.98% | +150.00% | 9.24B | |
| +0.45% | +3.73% | +25.09% | +46.01% | 7.83B | |
| -1.41% | -0.16% | +52.26% | -11.99% | 7.34B | |
| +0.89% | +9.50% | +26.11% | +220.67% | 7.21B | |
| +0.95% | -8.22% | -39.88% | +16.67% | 5.28B | |
| Average | +1.11% | +1.35% | +16.03% | +70.83% | 14.95B | |
| Weighted average by Cap. | +0.57% | +1.06% | +27.29% | +86.17% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 512M 76.12M 65.34M 61.17M 56.02M 106M 7.27B 106M 724M 283M 3.66B 286M 280M 12.13B | 447M 66.44M 57.03M 53.4M 48.89M 92.11M 6.35B 92.37M 632M 247M 3.2B 249M 244M 10.58B |
| Net income | 128M 19M 16.31M 15.27M 13.98M 26.34M 1.81B 26.41M 181M 70.68M 915M 71.33M 69.79M 3.03B | 47.48M 7.06M 6.06M 5.68M 5.2M 9.79M 675M 9.82M 67.23M 26.28M 340M 26.52M 25.95M 1.13B |
| Net Debt | -734M -109M -93.68M -87.71M -80.31M -151M -10.42B -152M -1.04B -406M -5.25B -410M -401M -17.39B | -746M -111M -95.33M -89.25M -81.73M -154M -10.61B -154M -1.06B -413M -5.35B -417M -408M -17.69B |
Employees
319
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-27 | CN¥9.780 | +0.62% | 5,137,775 |
| 26-08-26 | CN¥9.720 | -2.02% | 6,249,619 |
| 26-08-25 | CN¥9.920 | +5.08% | 8,043,235 |
| 26-08-24 | CN¥9.440 | -3.28% | 8,098,724 |
| 26-08-21 | CN¥9.760 | -4.41% | 11,070,288 |
- Stock Market
- Stocks
- 688247 Stock
Select your edition
All financial news and data tailored to specific country editions
